Indication
Genital Herpes
1 clinical trial
1 product
Product
UB-621Clinical trial
A Randomized, Single-blind, Placebo-control, Parallel, Phase II Trial to Evaluate the Safety and Efficacy of UB-621 in Adults With Recurrent Genital HSV-2 InfectionStatus: Not yet recruiting, Estimated PCD: 2025-12-01